Analystreport

Nektar Therapeutics (NASDAQ: NKTR) had its price target lowered by analysts at Mizuho from $8.00 to $6.00.

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations